Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-20022025-261201
EXTRAORDINARY
PART II-Section 3-Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 903]
NEW DELHI, THURSDAY, FEBRUARY 20, 2025/PHALGUNA 1, 1946
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
CORRIGENDUM
New Delhi, the 20th February, 2025
S.O. 910(E). In the National Pharmaceutical Pricing Authority's notification S.O. 659(E) of 7th February
2025 published in the Gazette of India, Extraordinary relating to revision of ceiling price based on review order, in
Hindi version, the dosage form and strength in column (3) for Entry at Sl. No. 1 related to Azithromycin shall be
read as "Tablet 250mg" in place of "Tablet 500mg".
[PN/261/129/2025/F/F. No. 8(129)/2025/D.P./NPPA-Div.-II]
MAHAVEER SAINI, Dy. Director